| 17/11/22 | 14:00:33 | 17 Nov 2022 | | Price Monitoring Extension |
| 17/11/22 | 07:00:07 | 17 Nov 2022 | | Capital Markets Day |
| 15/11/22 | 10:36:28 | 15 Nov 2022 | | Poolbeg-led consortium awarded EUR 2.3m grant |
| 08/11/22 | 07:00:04 | 8 Nov 2022 | | AI programme yields novel RSV drug targets |
| 21/10/22 | 07:00:03 | 21 Oct 2022 | | Upcoming events participation |
| 06/10/22 | 16:40:57 | 6 Oct 2022 | | Second Price Monitoring Extn |
| 06/10/22 | 16:35:53 | 6 Oct 2022 | | Price Monitoring Extension |
| 06/10/22 | 07:00:09 | 6 Oct 2022 | | CEO Share Purchase |
| 04/10/22 | 07:00:05 | 4 Oct 2022 | | POLB 001 US Patent update |
| 21/09/22 | 07:00:03 | 21 Sept 2022 | | Poolbeg licence of Melioidosis vaccine candidate |
| 12/09/22 | 07:00:08 | 12 Sept 2022 | | HC Wainwright Global Investment Conference |
| 06/09/22 | 14:05:59 | 6 Sept 2022 | | Second Price Monitoring Extn |
| 06/09/22 | 14:00:53 | 6 Sept 2022 | | Price Monitoring Extension |
| 06/09/22 | 07:00:13 | 6 Sept 2022 | | Interim Results |
| 31/08/22 | 07:25:49 | 31 Aug 2022 | | Notice of Results |
| 29/07/22 | 07:00:11 | 29 Jul 2022 | | Appointment of Joint Broker |
| 20/07/22 | 07:00:06 | 20 Jul 2022 | | POLB001 human challenge clinical trial to commence |
| 12/07/22 | 14:06:01 | 12 Jul 2022 | | Second Price Monitoring Extn |
| 12/07/22 | 14:00:34 | 12 Jul 2022 | | Price Monitoring Extension |
| 27/06/22 | 07:00:05 | 27 Jun 2022 | | Project update for AI model of RSV data |
| 21/06/22 | 16:40:47 | 21 Jun 2022 | | Second Price Monitoring Extn |
| 21/06/22 | 16:36:08 | 21 Jun 2022 | | Price Monitoring Extension |
| 26/05/22 | 14:05:50 | 26 May 2022 | | Second Price Monitoring Extn |
| 26/05/22 | 14:00:25 | 26 May 2022 | | Price Monitoring Extension |
| 26/05/22 | 07:00:07 | 26 May 2022 | | US patents granted for POLB 001 and POLB 002 |
| 25/05/22 | 16:40:36 | 25 May 2022 | | Second Price Monitoring Extn |
| 25/05/22 | 16:35:27 | 25 May 2022 | | Price Monitoring Extension |
| 23/05/22 | 13:01:01 | 23 May 2022 | | TR-1: Notification of major interest in shares |
| 12/05/22 | 07:00:07 | 12 May 2022 | | GMP manufacturing contract signed |
| 11/05/22 | 07:00:05 | 11 May 2022 | | Attendance at European Melioidosis Congress |
| 27/04/22 | 07:00:11 | 27 Apr 2022 | | Distribution in Specie update |
| 14/04/22 | 07:00:05 | 14 Apr 2022 | | Key POLB 002 European Patent Granted |
| 11/04/22 | 07:00:09 | 11 Apr 2022 | | Distribution in Specie Shareholders |
| 04/04/22 | 12:26:51 | 4 Apr 2022 | | Result of AGM |
| 31/03/22 | 07:00:08 | 31 Mar 2022 | | POLB001 Update - Clinical Trial Agreement Signed |
| 30/03/22 | 07:00:06 | 30 Mar 2022 | | Commencement of trading on US OTCQB market |
| 24/03/22 | 07:00:07 | 24 Mar 2022 | | AI deal signed with CytoReason |
| 09/03/22 | 07:00:12 | 9 Mar 2022 | | Notice of AGM |
| 03/03/22 | 07:00:07 | 3 Mar 2022 | | Final Results |
| 28/02/22 | 07:00:10 | 28 Feb 2022 | | Notice of Results |
| 24/02/22 | 07:00:09 | 24 Feb 2022 | | Artificial Intelligence deal with OneThree Biotech |
| 31/01/22 | 07:00:08 | 31 Jan 2022 | | Confirmation of vaccine platform licence execution |
| 17/01/22 | 07:00:07 | 17 Jan 2022 | | Exclusive license of RNA-based immunotherapy asset |
| 16/12/21 | 07:00:06 | 16 Dec 2021 | | Poolbeg to develop oral vaccine delivery platform |
| 06/12/21 | 07:00:08 | 6 Dec 2021 | | Poolbeg signs option for new vaccine candidate |
| 25/11/21 | 07:00:02 | 25 Nov 2021 | | Scientific Advisory Board Appointment |
| 18/11/21 | 07:00:03 | 18 Nov 2021 | | Update on POLB 001 Clinical Development |
| 14/10/21 | 09:05:43 | 14 Oct 2021 | | Second Price Monitoring Extn |
| 14/10/21 | 09:00:26 | 14 Oct 2021 | | Price Monitoring Extension |
| 14/10/21 | 07:00:02 | 14 Oct 2021 | | PredictViral Patent Update |
